{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:15:46Z","timestamp":1791389746073,"version":"4.3.3"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["188GJHZ2023069MI"],"award-info":[{"award-number":["188GJHZ2023069MI"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFE0210600"],"award-info":[{"award-number":["2022YFE0210600"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2022LSW026"],"award-info":[{"award-number":["ZR2022LSW026"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173745"],"award-info":[{"award-number":["82173745"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2024A04J4313"],"award-info":[{"award-number":["2024A04J4313"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017692","name":"Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["GIBHBRP24-03"],"award-info":[{"award-number":["GIBHBRP24-03"]}],"id":[{"id":"10.13039\/501100017692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017692","name":"Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["GIBHBRP24-04"],"award-info":[{"award-number":["GIBHBRP24-04"]}],"id":[{"id":"10.13039\/501100017692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017692","name":"Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["011"],"award-info":[{"award-number":["011"]}],"id":[{"id":"10.13039\/501100017692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejmech.2026.118681","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T07:16:08Z","timestamp":1771226168000},"page":"118681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of novel indole derivatives as LRH-1 antagonists for the treatment of castration resistant prostate cancer"],"prefix":"10.1016","volume":"308","author":[{"given":"Kaiyuan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Jing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3601-0246","authenticated-orcid":false,"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118681_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejmech.2026.118681_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jsbmb.2015.05.010","article-title":"Mechanisms of drug resistance that target the androgen axis in castration resistant prostate cancer (CRPC)","volume":"153","author":"Penning","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2026.118681_bib3","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/PPO.0000000000000214","article-title":"Androgen receptor and beyond, targeting androgen signaling in castration-resistant prostate cancer","volume":"22","author":"Reichert","year":"2016","journal-title":"Cancer J."},{"key":"10.1016\/j.ejmech.2026.118681_bib4","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s12032-016-0759-3","article-title":"Targeting persistent androgen receptor signaling in castration-resistant prostate cancer","volume":"33","author":"Graham","year":"2016","journal-title":"Med. Oncol."},{"key":"10.1016\/j.ejmech.2026.118681_bib5","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.eururo.2014.09.049","article-title":"Understanding the mechanisms of androgen deprivation resistance in prostate cancer at the molecular level","volume":"67","author":"Karantanos","year":"2015","journal-title":"Eur. Urol."},{"key":"10.1016\/j.ejmech.2026.118681_bib6","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.euf.2016.11.013","article-title":"Understanding mechanisms of resistance in metastatic castration-resistant prostate cancer: the role of the androgen receptor","volume":"2","author":"Tilki","year":"2016","journal-title":"Eur. Urol. Focus"},{"key":"10.1016\/j.ejmech.2026.118681_bib7","doi-asserted-by":"crossref","first-page":"4267","DOI":"10.1200\/JCO.23.00433","article-title":"Targeting the androgen signaling axis in prostate cancer","volume":"41","author":"Dai","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2026.118681_bib8","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrurol.2016.221","article-title":"Androgen synthesis in prostate cancer: do all roads lead to Rome?","volume":"14","author":"Stuchbery","year":"2017","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.ejmech.2026.118681_bib9","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1158\/0008-5472.CAN-17-2341","article-title":"Nuclear receptor LRH-1 functions to promote castration-resistant growth of prostate cancer via its promotion of intratumoral androgen biosynthesis","volume":"78","author":"Xiao","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118681_bib10","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1158\/1078-0432.CCR-08-1171","article-title":"Castration-resistant prostate cancer: locking up the molecular escape routes","volume":"15","author":"Attar","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118681_bib11","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1080\/15384047.2015.1045693","article-title":"Liver receptor homolog-1 (LRH-1): a potential therapeutic target for cancer","volume":"16","author":"Nadolny","year":"2015","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ejmech.2026.118681_bib12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tcb.2004.03.008","article-title":"LRH-1: an orphan nuclear receptor involved in development, metabolism and steroidogenesis","volume":"14","author":"Fayard","year":"2004","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.ejmech.2026.118681_bib13","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1038\/s41401-024-01276-x","article-title":"Liver receptor homolog-1: structures, related diseases, and drug discovery","volume":"45","author":"Wu","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2026.118681_bib14","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1152\/physrev.00019.2018","article-title":"The orphan nuclear receptors steroidogenic factor-1 and liver receptor homolog-1: structure, regulation, and essential roles in mammalian reproduction","volume":"99","author":"Meinsohn","year":"2019","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejmech.2026.118681_bib15","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.2147\/CMAR.S162887","article-title":"LRH-1 drives hepatocellular carcinoma partially through induction of c-myc and cyclin E1, and suppression of p21","volume":"10","author":"Xiao","year":"2018","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.ejmech.2026.118681_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031593","article-title":"The orphan nuclear receptor LRH-1 and ERalpha activate GREB1 expression to induce breast cancer cell proliferation","volume":"7","author":"Chand","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.118681_bib17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1677\/ERC-10-0179","article-title":"The orphan nuclear receptor LRH-1 promotes breast cancer motility and invasion","volume":"17","author":"Chand","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ejmech.2026.118681_bib18","doi-asserted-by":"crossref","first-page":"10228","DOI":"10.1093\/nar\/gkt827","article-title":"Co-regulated gene expression by oestrogen receptor alpha and liver receptor homolog-1 is a feature of the oestrogen response in breast cancer cells","volume":"41","author":"Lai","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.118681_bib19","doi-asserted-by":"crossref","first-page":"16927","DOI":"10.1073\/pnas.1112047108","article-title":"Nuclear receptor liver receptor homologue 1 (LRH-1) regulates pancreatic cancer cell growth and proliferation","volume":"108","author":"Benod","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2026.118681_bib20","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3390\/ani12091213","article-title":"Liver receptor homolog-1 regulates apoptosis of bovine ovarian granulosa cells by progestogen receptor signaling pathway","volume":"12","author":"Xu","year":"2022","journal-title":"Animals"},{"key":"10.1016\/j.ejmech.2026.118681_bib21","doi-asserted-by":"crossref","first-page":"896","DOI":"10.3390\/cancers13040896","article-title":"Another one bites the gut: nuclear receptor LRH-1 in intestinal regeneration and cancer","volume":"13","author":"Zerlotin","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejmech.2026.118681_bib22","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1038\/s41388-021-01737-1","article-title":"Orphan nuclear receptors as regulators of intratumoral androgen biosynthesis in castration-resistant prostate cancer","volume":"40","author":"Zhou","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2026.118681_bib23","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1021\/jm060990k","article-title":"Identification of small molecule agonists of the orphan nuclear receptors liver receptor homolog-1 and steroidogenic factor-1","volume":"49","author":"Whitby","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118681_bib24","doi-asserted-by":"crossref","first-page":"11022","DOI":"10.1021\/acs.jmedchem.9b00753","article-title":"Development of the first low nanomolar liver receptor homolog-1 agonist through structure-guided design","volume":"62","author":"Mays","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118681_bib25","doi-asserted-by":"crossref","first-page":"6888","DOI":"10.1021\/acs.jmedchem.2c00235","article-title":"Differential modulation of nuclear receptor LRH-1 through targeting buried and surface regions of the binding pocket","volume":"65","author":"Cato","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118681_bib26","series-title":"Probe Reports from the NIH Molecular Libraries Program","article-title":"Discovery of inverse agonists for the liver receptor homologue-1 (LRH1; NR5A2)","author":"Busby","year":"2010"},{"key":"10.1016\/j.ejmech.2026.118681_bib27","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1002\/cmdc.201200307","article-title":"Discovery of a new class of liver receptor homolog-1 (LRH-1) antagonists: virtual screening, synthesis and biological evaluation","volume":"7","author":"Rey","year":"2012","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2026.118681_bib28","doi-asserted-by":"crossref","first-page":"19830","DOI":"10.1074\/jbc.M112.411686","article-title":"Structure-based discovery of antagonists of nuclear receptor LRH-1","volume":"288","author":"Benod","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118681_bib29","doi-asserted-by":"crossref","first-page":"9505","DOI":"10.1073\/pnas.0501204102","article-title":"Structural and biochemical basis for selective repression of the orphan nuclear receptor liver receptor homolog 1 by small heterodimer partner","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmech.2026.118681_bib30","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1074\/jbc.M110.168740","article-title":"The orphan nuclear receptor TR4 is a vitamin A-activated nuclear receptor","volume":"286","author":"Zhou","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118681_bib31","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1210\/me.2009-0507","article-title":"Structural basis for hydroxycholesterols as natural ligands of orphan nuclear receptor ROR\u03b3","volume":"24","author":"Jin","year":"2010","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ejmech.2026.118681_bib32","doi-asserted-by":"crossref","first-page":"8775","DOI":"10.1021\/acs.jmedchem.1c00763","article-title":"Discovery and characterization of benzimidazole derivative XY123 as a potent, selective, and orally available RORgamma inverse agonist","volume":"64","author":"Wu","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118681_bib33","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S1097-2765(03)00236-3","article-title":"Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1","volume":"11","author":"Sablin","year":"2003","journal-title":"Mol. Cell"},{"key":"10.1016\/j.ejmech.2026.118681_bib34","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1056\/NEJMoa1800536","article-title":"Enzalutamide in men with nonmetastatic, castration-resistant prostate cancer","volume":"378","author":"Hussain","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejmech.2026.118681_bib35","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1158\/1078-0432.CCR-25-2546","article-title":"Drug targets in prostate cancer: an appetite for KLK2-mediated destruction","volume":"31","author":"Blinka","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.118681_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17233742","article-title":"The clinical relevance of tumor biomarkers in prostate cancer-A review","volume":"17","author":"Majewska","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2026.118681_bib37","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1038\/s41388-019-0768-8","article-title":"A positive role of c-Myc in regulating androgen receptor and its splice variants in prostate cancer","volume":"38","author":"Bai","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2026.118681_bib38","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1038\/s41467-022-30257-z","article-title":"MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets","volume":"13","author":"Qiu","year":"2022","journal-title":"Nat. Commun."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426001261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426001261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T21:10:59Z","timestamp":1779743459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426001261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":38,"alternative-id":["S0223523426001261"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118681","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of novel indole derivatives as LRH-1 antagonists for the treatment of castration resistant prostate cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118681"}}